The Changing Drug Culture: Medical and Recreational Marijuana

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

The major psychoactive compounds in marijuana (cannabis) are cannabinoids, the most significant of which is delta-9-tetrahydrocannabinol. There are also two synthetic pharmaceutical cannabinoids, nabilone and dronabinol, available by prescription in the United States. The use of marijuana has increased in the United States with passage of medical marijuana laws in many states and legalization of recreational marijuana use in several states. In addition, the potency of marijuana has increased in recent years. Marijuana has been used for a variety of medical purposes, including management of nausea and vomiting, appetite and immunologic stimulation in patients with HIV infection and AIDS, glaucoma, neurologic disorders, and pain relief. Studies on the benefits of marijuana as a treatment for various conditions have been inconsistent, except for those on pain management. Marijuana has adverse effects, and has been associated with driving impairment, psychosis, dependence and withdrawal syndromes, hyperemesis, acute cardiac events, some cancers, and impaired lung function. As with studies on the benefits of marijuana, studies of adverse effects have yielded inconsistent results. Except for impaired driving and the occurrence of dependence and withdrawal syndromes, the adverse effects of marijuana use have not been fully studied.

Original languageEnglish (US)
Pages (from-to)11-17
Number of pages7
JournalFP essentials
Volume441
StatePublished - Feb 1 2016

Fingerprint

Medical Marijuana
Cannabis
Pharmaceutical Preparations
Dronabinol
Cannabinoids
Appetite
Pain Management
Nervous System Diseases
Glaucoma
Psychotic Disorders
Nausea
HIV Infections
Vomiting
Prescriptions
Immunization
Lung Neoplasms
Acquired Immunodeficiency Syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The Changing Drug Culture : Medical and Recreational Marijuana. / Albertson, Timothy E; Chenoweth, James; Colby, Daniel; Sutter, Mark E.

In: FP essentials, Vol. 441, 01.02.2016, p. 11-17.

Research output: Contribution to journalReview article

@article{0a02e795c64d40799e77aa5fc9cb9362,
title = "The Changing Drug Culture: Medical and Recreational Marijuana",
abstract = "The major psychoactive compounds in marijuana (cannabis) are cannabinoids, the most significant of which is delta-9-tetrahydrocannabinol. There are also two synthetic pharmaceutical cannabinoids, nabilone and dronabinol, available by prescription in the United States. The use of marijuana has increased in the United States with passage of medical marijuana laws in many states and legalization of recreational marijuana use in several states. In addition, the potency of marijuana has increased in recent years. Marijuana has been used for a variety of medical purposes, including management of nausea and vomiting, appetite and immunologic stimulation in patients with HIV infection and AIDS, glaucoma, neurologic disorders, and pain relief. Studies on the benefits of marijuana as a treatment for various conditions have been inconsistent, except for those on pain management. Marijuana has adverse effects, and has been associated with driving impairment, psychosis, dependence and withdrawal syndromes, hyperemesis, acute cardiac events, some cancers, and impaired lung function. As with studies on the benefits of marijuana, studies of adverse effects have yielded inconsistent results. Except for impaired driving and the occurrence of dependence and withdrawal syndromes, the adverse effects of marijuana use have not been fully studied.",
author = "Albertson, {Timothy E} and James Chenoweth and Daniel Colby and Sutter, {Mark E}",
year = "2016",
month = "2",
day = "1",
language = "English (US)",
volume = "441",
pages = "11--17",
journal = "FP essentials",
issn = "2159-3000",
publisher = "American Academy of Family Physicians",

}

TY - JOUR

T1 - The Changing Drug Culture

T2 - Medical and Recreational Marijuana

AU - Albertson, Timothy E

AU - Chenoweth, James

AU - Colby, Daniel

AU - Sutter, Mark E

PY - 2016/2/1

Y1 - 2016/2/1

N2 - The major psychoactive compounds in marijuana (cannabis) are cannabinoids, the most significant of which is delta-9-tetrahydrocannabinol. There are also two synthetic pharmaceutical cannabinoids, nabilone and dronabinol, available by prescription in the United States. The use of marijuana has increased in the United States with passage of medical marijuana laws in many states and legalization of recreational marijuana use in several states. In addition, the potency of marijuana has increased in recent years. Marijuana has been used for a variety of medical purposes, including management of nausea and vomiting, appetite and immunologic stimulation in patients with HIV infection and AIDS, glaucoma, neurologic disorders, and pain relief. Studies on the benefits of marijuana as a treatment for various conditions have been inconsistent, except for those on pain management. Marijuana has adverse effects, and has been associated with driving impairment, psychosis, dependence and withdrawal syndromes, hyperemesis, acute cardiac events, some cancers, and impaired lung function. As with studies on the benefits of marijuana, studies of adverse effects have yielded inconsistent results. Except for impaired driving and the occurrence of dependence and withdrawal syndromes, the adverse effects of marijuana use have not been fully studied.

AB - The major psychoactive compounds in marijuana (cannabis) are cannabinoids, the most significant of which is delta-9-tetrahydrocannabinol. There are also two synthetic pharmaceutical cannabinoids, nabilone and dronabinol, available by prescription in the United States. The use of marijuana has increased in the United States with passage of medical marijuana laws in many states and legalization of recreational marijuana use in several states. In addition, the potency of marijuana has increased in recent years. Marijuana has been used for a variety of medical purposes, including management of nausea and vomiting, appetite and immunologic stimulation in patients with HIV infection and AIDS, glaucoma, neurologic disorders, and pain relief. Studies on the benefits of marijuana as a treatment for various conditions have been inconsistent, except for those on pain management. Marijuana has adverse effects, and has been associated with driving impairment, psychosis, dependence and withdrawal syndromes, hyperemesis, acute cardiac events, some cancers, and impaired lung function. As with studies on the benefits of marijuana, studies of adverse effects have yielded inconsistent results. Except for impaired driving and the occurrence of dependence and withdrawal syndromes, the adverse effects of marijuana use have not been fully studied.

UR - http://www.scopus.com/inward/record.url?scp=84975258028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975258028&partnerID=8YFLogxK

M3 - Review article

C2 - 26881768

AN - SCOPUS:84975258028

VL - 441

SP - 11

EP - 17

JO - FP essentials

JF - FP essentials

SN - 2159-3000

ER -